PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • Sustainability
  • Investor Relations
  • Newsroom

About Us

About PHC GroupCEO MessageMission, Vision & ValuesValue Creation PlanHistory LeadershipPHC Group by the Numbers

Group Companies

Ascensia LSI Medience Wemex Mediford Epredia PHCbi PHC IVD

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

Sustainability

Sustainability
  • CEO Message
  • Materiality
  • Sustainability Management
  • PHC GROUP Integrated Report
  • Stakeholder Engagement
  • Environment image
    Environment
  • Society image
    Social
  • Governance image
    Governance

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy
  • Business Risks

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials
  • Historical Financial Data
  • PHC GROUP Integrated Report
  • Mid-term Plan
  • Our Group Introduction

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Shareholder Newsletter
  • Stock Quotations
  • Analyst Coverage
IR News Financial Highlights IR Calendar Contact IR Disclaimer

Newsroom

NEWSROOM

NEWS

  • PHC Holdings Corporation
  • PHC Group Companies
CareersContact
JP

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation
CareersContactJP
Newsroom > 2020 > Company Operations During COVID-19 Imposed State of Emergency in Aichi Prefecture

News


2020

AnnouncementApril 10

Company Operations During COVID-19 Imposed State of Emergency in Aichi Prefecture

Our sincere condolences to victims of COVID-19, and hopes for the quick recovery of those who have been infected.

Responding to the Aichi Prefecture’s state of emergency declared on April 10 regarding COVID-19, PHC Holdings Corporation (headquarters: Tokyo, Japan) will be closing the company site below from April 13, prioritizing the safety of customers and employees. During the closure, PHC Group employees at the site will continue business operations by working from home, except in special cases where they perform essential duties that cannot be performed remotely, and will respond to customer inquiries by e-mail, phone calls, etc.

· Site closures

PHC Corporation [Biomedical Division]
 Chubu Sales Office/Pharmacy System Sales Office/Delicart Sales Office
(Address: Nagoya Panasonic Building 6F, 1-23-30 Izumi, Higashi-ku, Nagoya City, Aichi)

Details of additional upcoming measures at the above site will be announced respectively by the business division in charge, where appropriate. Resuming of operations at the site will be considered depending on national and local government policies and the status of the COVID-19. We appreciate your understanding and apologize for any inconvenience or disruption that you may experience. Details for other PHC Group companies will be announced separately and we ask you to refer to each company‘s website for further information.

The PHC Group will continue to protect the safety of our customers and employees, while minimizing the effects on customers and patients who rely on our products and services.

Media contact

Corporate Communications Group
PHC Holdings Corporation
+81-3-6778-5311

  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.